Xiangyu Medical Competitors and Similar CompaniesClear all

Xiangyu Medical's competitors and similar companies include Endologix, Apria Healthcare Group, Shanghai Sanyou Medical and Lincare.

	Xiangyu Medical Xiangyu Medical (河南翔宇医疗设备股份有限公司) is a company that specializes in the research and development, manufacturing, and marketing of rehabilitation, physiotherapy equipment, and pain management equipment.	Endologix Endologix is a medical device company that provides therapies for the treatment of vascular disease.	Apria Healthcare Group Apria Healthcare Group is a company that provides home respiratory services and medical equipment.	Shanghai Sanyou Medical Shanghai Sanyou Medical (上海三友医疗器械股份有限公司) researches, develops, manufactures, and supplies orthopedics implant products.	Lincare Lincare is a company that provides respiratory therapy services.
Founding Date	Founding Date 2002	Founding Date 1992	Founding Date N/A	Founding Date 2005	Founding Date N/A
Type	Type Public	Type Subsidiary	Type Subsidiary	Type Public	Type Private
Tags	Tags Healthcare medical devices therapy	Tags Healthcare medical devices therapy	Tags Healthcare medical devices therapy	Tags Healthcare medical devices therapy	Tags Healthcare medical devices therapy
Locations	Locations Anyang, CN HQ	Locations Irvine, US HQ 's Hertogenbosch, NL Milpitas, US Santa Rosa, US	Locations Indianapolis, US HQ Lake Forest, US	Locations CN HQ	Locations Clearwater, US HQ
Employees	Employees 2,34129% increase	Employees 4351% increase	Employees 5,666	Employees 466	Employees 5,4731% increase
Valuation ($)	Valuation ($) 625.1 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 752.5 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) ¥727.5m (FY, 2025)	Revenue (est.) $143.4m (FY, 2019)	Revenue (est.) $1.1b (FY, 2021)	Revenue (est.) ¥446m (FY, 2024)	Revenue (est.) N/A
Cost of goods	Cost of goods ¥256.2m (FY, 2025)	Cost of goods $52.3m (FY, 2019)	Cost of goods $341.3m (FY, 2021)	Cost of goods ¥130m (FY, 2024)	Cost of goods N/A
Gross profit	Gross profit ¥498.3m (FY, 2025)	Gross profit $91.1m (FY, 2019)	Gross profit $804m (FY, 2021)	Gross profit ¥317.9m (FY, 2024)	Gross profit N/A
Net income	Net income ¥76m (FY, 2025)	Net income ($64.8m) (FY, 2019)	Net income $64.9m (FY, 2021)	Net income ¥12.1m (FY, 2024)	Net income N/A